BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LY4006896 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of LY4006896\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06809400-1702@assetmemo.bio
DTSTAMP:20261121T005642Z
DTSTART;VALUE=DATE:20281031
DTEND;VALUE=DATE:20281101
SUMMARY:LY4006896: Phase 1 readout est. (NCT06809400)
DESCRIPTION:LY4006896\, phase 1\, Parkinson's Disease.\nStudy: A Study of L
 Y4006896 in Healthy Participants and Participants With Parkinson's Disease
 \nEstimated primary completion: October 2028. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/ly4006896#upcoming-events\nRegistry record: https
 ://clinicaltrials.gov/study/NCT06809400
URL:https://assetmemo.bio/drug/ly4006896#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
